Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
91-105 of 1283 results
MIMETAS, Galapagos to develop human disease models on-a-chip technology
14 January 2014 | By PBR Staff Writer
MIMETAS and Galapagos have entered into a research collaboration to develop organ-on-a-chip-based human disease models for new medicine development.
Automation > IT & Software > News
Marina Biotech announces issuance of patents for Smarticles nucleic acid delivery technology
10 January 2014
Marina Biotech, an oligonucleotide-based drug discovery and development company, announced the grant and issuance of patents relating to the company's proprietary nucleic-acid delivery technology, Smarticles.
Automation > IT & Software > News
Spinomix announces a milestone payment from Debiopharm
09 January 2014
Switzerland-based Spinomix and biopharmaceutical company Debiopharm Group have announced the successful achievement of a second development milestone on Spinomix’s two proprietary technologies, namely MagPhase and FibroTrap.
Automation > IT & Software > News
Immunocore, MedImmune partner to develop new cancer therapies using ImmTAC technology
09 January 2014 | By PBR Staff Writer
UK-based biotechnology firm Immunocore has entered into an oncology research collaboration and licensing agreement with AstraZeneca's global biologics research and development arm MedImmune.
Automation > IT & Software > News
Memorial Sloan-Kettering to use Sutro's technology for new bispecific antibodies
08 January 2014 | By PBR Staff Writer
US-based biopharmaceutical firm Sutro Biopharma has entered into a collaboration agreement with Memorial Sloan-Kettering Cancer Center to produce bispecific antibodies for the treatment of neuroblastoma.
Automation > IT & Software > News
Adamis Pharmaceuticals announces completion of acquisition of 3M assets
08 January 2014
Adamis Pharmaceuticals has announced that at a closing held on 27 December 2013, the company made a final payment of $7m to fully acquire from 3M Company and 3M Innovative Properties Company certain intellectual property and assets relating to 3M's Taper Dry Powder Inhaler technology under development for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Automation > IT & Software > News
Ossianix, Lundbeck to develop new biopharmaceuticals
07 January 2014 | By PBR Staff Writer
Ossianix has entered into a strategic research collaboration with Lundbeck, which follows a previous investment in 2012.
Automation > IT & Software > News
Galectin Therapeutics receives US patent for combination treatment for liver fibrosis
07 January 2014
Galectin Therapeutics has received a notice of allowance from the US Patent and Trademark Office titled ‘Galactose-Pronged Polysaccharides in a Formulation for Anti-fibrotic Therapies’.
Automation > IT & Software > News
GE Healthcare to acquire strategic assets from Thermo Fisher for $1.06bn
07 January 2014 | By PBR Staff Writer
GE Healthcare, a unit of General Electric Company (GE), has entered into an agreement with Thermo Fisher Scientific (TMO) to acquire Thermo Fisher’s HyClone cell culture media and sera, and gene modulation and magnetic beads businesses.
Automation > IT & Software > News
Dohmen announces acquisition of three technology companies; Red Arrow, Clinical Path Consulting and ChemWare
06 January 2014
CEO Cynthia (Dohmen) LaConte announced that Dohmen has acquired three technology companies; Red Arrow Labs, Clinical Path Consulting and ChemWare. Founder of two of the companies, Mark Grosskopf will join Dohmen as the CIO of Dohmen Life Science Services and will continue to serve as president of all three companies going forward.
Automation > IT & Software > News
Agilis Biotherapeutics, Intrexon collaborate to develop DNA-based therapeutics for rare genetic disease
02 January 2014
Agilis Biotherapeutics and Intrexon have signed an Exclusive Channel Collaboration (ECC) agreement to develop DNA-based therapeutics for Friedreich's ataxia (FRDA), a rare genetic neurodegenerative disease.
Automation > IT & Software > News
Antares Pharma announces notice of allowance for new patent on reconstitutable lyophilized injectables
23 December 2013
Antares Pharma announced that it has received a Notice of Allowance from the U.S. Patent Office for application 13/584,317. This application, along with U.S. Patent 8,251,947 granted in August of 2012, relate to Antares’ injector technology for wet-dry injectable drugs such as lyophilized biologicals or peptide drugs that require dry storage to assure stability.
Automation > IT & Software > News
Blaze starts Phase I trial of Tumor Paint technology BLZ-100
20 December 2013 | By PBR Staff Writer
Blaze Bioscience and its subsidiary Blaze Bioscience Australia have started the first Phase I clinical trial of the first Tumor Paint product candidate, BLZ-100.
Automation > IT & Software > News
Vector Capital sells Certara to Arsenal Capital
20 December 2013
Vector Capital, private equity firm focused on value-oriented investments in technology companies, has sold Certara, a provider of drug development software and services, to Arsenal Capital Partners, a US-based based private equity firm.
Automation > IT & Software > News
OvaScience and Intrexon collaborate to accelerate development of OvaTure technology for infertility treatments
20 December 2013
OvaScience, a life sciences company, and Intrexon Corporation have announced an agreement to access Intrexon’s portfolio of technologies to accelerate the development of OvaScience’s OvaTure technology platform.
Automation > IT & Software > News
91-105 of 1283 results